Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
Research funded by the Agency for Healthcare Research and Quality found insufficient evidence to determine the accuracy — or ...
Swansea University has helped uncover a surprising new role for platelets—one that could significantly advance early cancer detection. The study, led by the University of Oxford and published in ...
Medical Device Network on MSN
Northwestern University announces new RNA detection method for cancer
The study introduced LIME-seq, a new non-invasive technique capable of detecting RNA modifications at a detailed level across ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Is our health system ready for multi-cancer detection tests? That was the question Fred Hutch's Dr. Scott Ramsey and others posed at a full-day Cancer Screening Intelligence for the Future symposium ...
HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive cervical cancer, offering valuable insights for guiding clinical decisions in ...
For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...
A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback